{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:46:21Z","timestamp":1768920381487,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC112-2221-E-705-001-MY2"],"award-info":[{"award-number":["NSTC112-2221-E-705-001-MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.thromres.2025.109332","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T22:59:40Z","timestamp":1745621980000},"page":"109332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Comparative effectiveness and safety of direct oral anticoagulants in atrial fibrillation patients with dementia"],"prefix":"10.1016","volume":"250","author":[{"given":"Chen-Wen","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Yang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Fang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Feng","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2025.109332_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101092","article-title":"Atrial fibrillation in the elderly: a risk factor beyond stroke","volume":"61","author":"Bencivenga","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.thromres.2025.109332_bb0010","article-title":"Correlates of dementia and mild cognitive impairment in patients with atrial fibrillation: the atherosclerosis risk in communities neurocognitive study (ARIC-NCS)","volume":"6","author":"Alonso","year":"2017","journal-title":"J. Am. Hear. Assoc."},{"key":"10.1016\/j.thromres.2025.109332_bb0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fnins.2019.00018","article-title":"Atrial fibrillation and risk of dementia: epidemiology, mechanisms, and effect of anticoagulation","volume":"13","author":"Silva","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.thromres.2025.109332_bb0020","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1161\/STROKEAHA.114.005243","article-title":"Atrial fibrillation and cognitive decline\u2013the role of subclinical cerebral infarcts","volume":"45","author":"Chen","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2025.109332_bb0025","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCULATIONAHA.121.055018","article-title":"Atrial fibrillation and dementia: a report from the AF-SCREEN international collaboration","volume":"145","author":"Rivard","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2025.109332_bb0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.4086","article-title":"Comparative effectiveness and safety of Oral anticoagulants by dementia status in older patients with atrial fibrillation","volume":"6","author":"Lin","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"2024","key":"10.1016\/j.thromres.2025.109332_bb0035","first-page":"e1","article-title":"ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2023","journal-title":"Circulation"},{"issue":"2024","key":"10.1016\/j.thromres.2025.109332_bb0040","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Gelder","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2025.109332_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2017.10.036","article-title":"A. for R. in S.O.T.E. in A.F. (ARISTOTLE) Investigators, clinical outcomes and history of fall in patients with atrial fibrillation treated with oral anticoagulation: insights from the ARISTOTLE trial","volume":"131","author":"Rao","year":"2018","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2025.109332_bb0050","doi-asserted-by":"crossref","first-page":"1265331","DOI":"10.3389\/fcvm.2023.1265331","article-title":"Clinical benefits of oral anticoagulants in atrial fibrillation patients with dementia: a systematic review and meta-analysis","volume":"10","author":"Wang","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.thromres.2025.109332_bb0055","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/23969873241274598","article-title":"Comparative effectiveness and safety of direct oral anticoagulants and warfarin in atrial fibrillation patients with dementia","volume":"10","author":"Fang","year":"2025","journal-title":"Eur. Stroke J."},{"key":"10.1016\/j.thromres.2025.109332_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2024.04.009","article-title":"Oral anticoagulant therapy in older adults","volume":"238","author":"Stuby","year":"2024","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109332_bb0065","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/CLEP.S196293","article-title":"Taiwan\u2019s national health insurance research database: past and future","volume":"11","author":"Hsieh","year":"2019","journal-title":"Clin Epidemiology"},{"key":"10.1016\/j.thromres.2025.109332_bb0070","doi-asserted-by":"crossref","DOI":"10.2196\/18457","article-title":"Two decades of research using Taiwan\u2019s National Health Insurance Claims Data: bibliometric and text mining analysis on PubMed","volume":"22","author":"Sung","year":"2020","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.thromres.2025.109332_bb0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2016.04.069","article-title":"Validation of algorithms to identify stroke risk factors in patients with acute ischemic stroke, transient ischemic attack, or intracerebral hemorrhage in an administrative claims database","volume":"215","author":"Sung","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.thromres.2025.109332_bb0080","first-page":"327","article-title":"Validation of stroke risk factors in patients with acute ischemic stroke, transient ischemic attack, or intracerebral hemorrhage on Taiwan\u2019s National Health Insurance Claims Data, Clin","volume":"14","author":"Hsieh","year":"2022","journal-title":"Epidemiology"},{"key":"10.1016\/j.thromres.2025.109332_bb0085","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jalz.2018.02.016","article-title":"Identifying dementia cases with routinely collected health data: a systematic review","volume":"14","author":"Wilkinson","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.thromres.2025.109332_bb0090","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/pds.5608","article-title":"Validation of diagnosis codes in healthcare databases in Taiwan, a literature review","volume":"32","author":"Huang","year":"2023","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.thromres.2025.109332_bb0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2025.109332_bb0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2025.109332_bb0105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.hrthm.2024.01.025","article-title":"Comparison of different direct oral anticoagulant regimens in atrial fibrillation patients with high bleeding risk","volume":"21","author":"Ciou","year":"2024","journal-title":"Hear. Rhythm"},{"key":"10.1016\/j.thromres.2025.109332_bb0110","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/8755122516646384","article-title":"Administration of Direct Oral Anticoagulants through Enteral Feeding Tubes","volume":"32","author":"Peterson","year":"2016","journal-title":"J. Pharm. Technol."},{"key":"10.1016\/j.thromres.2025.109332_bb0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2147\/IJNRD.S105771","article-title":"Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations","volume":"10","author":"Lutz","year":"2017","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"10.1016\/j.thromres.2025.109332_bb0120","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12933-023-01991-5","article-title":"Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study","volume":"22","author":"Peng","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.thromres.2025.109332_bb0125","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s007020200068","article-title":"Alzheimer disease and cerebrovascular pathology: an update","volume":"109","author":"Jellinger","year":"2002","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.thromres.2025.109332_bb0130","doi-asserted-by":"crossref","first-page":"14482","DOI":"10.1073\/pnas.1921327117","article-title":"Cerebral amyloid angiopathy-linked \u03b2-amyloid mutations promote cerebral fibrin deposits via increased binding affinity for fibrinogen","volume":"117","author":"Cajamarca","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.thromres.2025.109332_bb0135","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","article-title":"Vascular dysfunction\u2014the disregarded partner of Alzheimer\u2019s disease","volume":"15","author":"Sweeney","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.thromres.2025.109332_bb0140","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.rcl.2023.01.009","article-title":"Cerebral amyloid Angiopathy","volume":"61","author":"Szidonya","year":"2023","journal-title":"Radiol. Clin. North Am."},{"key":"10.1016\/j.thromres.2025.109332_bb0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1160\/TH07-03-0183","article-title":"In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate","volume":"98","author":"Wienen","year":"2007","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109332_bb0150","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.4103\/1673-5374.303029","article-title":"Direct oral anticoagulants: a new therapy against Alzheimer\u2019s disease?","volume":"16","author":"Grossmann","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.thromres.2025.109332_bb0155","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3233\/JAD-200610","article-title":"Anticoagulants for treatment of Alzheimer\u2019s disease","volume":"77","author":"Grossmann","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.thromres.2025.109332_bb0160","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3389\/fneur.2019.00966","article-title":"Effects of dabigatran in mouse models of aging and cerebral amyloid Angiopathy","volume":"10","author":"Michael","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.thromres.2025.109332_bb0165","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/STROKEAHA.117.017994","article-title":"Cerebral microbleeds in murine amyloid angiopathy","volume":"48","author":"Marinescu","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2025.109332_bb0170","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/STROKEAHA.119.025623","article-title":"Low-dose rivaroxaban and risks of adverse events in patients with atrial fibrillation","volume":"50","author":"Cheng","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2025.109332_bb0175","article-title":"Comparisons of rivaroxaban following different dosage criteria (ROCKET AF or J-ROCKET AF trials) in Asian patients with atrial fibrillation","volume":"8","author":"Chan","year":"2019","journal-title":"J. Am. Hear. Assoc.: Cardiovasc. Cerebrovasc. Dis."},{"key":"10.1016\/j.thromres.2025.109332_bb0180","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad288","article-title":"Comparisons of effectiveness and safety between on-label dosing, off-label underdosing, and off-label overdosing in Asian and non-Asian atrial fibrillation patients treated with rivaroxaban: a systematic review and meta-analysis of observational studies","volume":"25","author":"Chan","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.thromres.2025.109332_bb0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jacc.2018.04.084","article-title":"Effectiveness and safety of standard- and low-dose rivaroxaban in Asians with atrial fibrillation","volume":"72","author":"Lin","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2025.109332_bb0190","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/cpt.1601","article-title":"Real-world rivaroxaban and Apixaban levels in Asian patients with atrial fibrillation","volume":"107","author":"Lin","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2025.109332_bb0195","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/cpt.2927","article-title":"Impact of direct oral anticoagulant concentration on clinical outcomes in Asian patients with atrial fibrillation","volume":"114","author":"Lin","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2025.109332_bb0200","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10654-021-00751-7","article-title":"Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis","volume":"36","author":"Zhang","year":"2021","journal-title":"Eur. J. Epidemiology"},{"key":"10.1016\/j.thromres.2025.109332_bb0205","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.7326\/M22-0511","article-title":"Comparative effectiveness and safety between Apixaban, dabigatran, edoxaban, and rivaroxaban among patients with atrial fibrillation: a multinational population-based cohort study","volume":"175","author":"Lau","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2025.109332_bb0210","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/eurheartj\/ehy807","article-title":"Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial","volume":"40","author":"Chao","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2025.109332_bb0215","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/0897190019894142","article-title":"Racial and ethnic differences in response to anticoagulation: a review of the literature","volume":"34","author":"Gibson","year":"2021","journal-title":"J. Pharm. Pr."},{"key":"10.1016\/j.thromres.2025.109332_bb0220","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1111\/jgs.17183","article-title":"Identifying medicare beneficiaries with dementia","volume":"69","author":"Moura","year":"2021","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.thromres.2025.109332_bb0225","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ckj\/sfaa076","article-title":"Health claims databases used for kidney research around the world","volume":"14","author":"van Oosten","year":"2020","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.thromres.2025.109332_bb0230","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7326\/0003-4819-134-7-200104030-00010","article-title":"Confounding by contraindication in a nationwide cohort study of risk for death in patients taking ibopamine","volume":"134","author":"Feenstra","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2025.109332_bb0235","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/ckj\/sfaa242","article-title":"Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them","volume":"14","author":"Fu","year":"2020","journal-title":"Clin. Kidney J."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T16:58:35Z","timestamp":1747414715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825000817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":47,"alternative-id":["S0049384825000817"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109332","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness and safety of direct oral anticoagulants in atrial fibrillation patients with dementia","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109332"}}